| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,249 |
1,923 |
$179K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
910 |
858 |
$103K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
914 |
861 |
$100K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
351 |
315 |
$26K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
480 |
307 |
$23K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
485 |
447 |
$16K |
| 0002A |
|
372 |
340 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,034 |
905 |
$12K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
482 |
348 |
$12K |
| 0001A |
|
399 |
350 |
$10K |
| 87634 |
|
152 |
150 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
229 |
193 |
$9K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
36 |
35 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
582 |
178 |
$4K |
| 0004A |
|
103 |
101 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
136 |
88 |
$1K |
| 0072A |
|
37 |
37 |
$1K |
| 0071A |
|
21 |
21 |
$809.60 |
| 71046 |
Radiologic examination, chest; 2 views |
14 |
12 |
$408.37 |
| 0054A |
|
12 |
12 |
$406.40 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
91 |
68 |
$182.88 |
| 87807 |
|
16 |
13 |
$172.12 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
62 |
57 |
$115.65 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
14 |
$90.06 |
| 94761 |
|
13 |
13 |
$38.21 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
27 |
26 |
$26.94 |
| 81003 |
|
12 |
12 |
$25.10 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
12 |
12 |
$22.72 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
12 |
$15.36 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
12 |
12 |
$1.98 |
| 91300 |
|
105 |
87 |
$0.35 |
| 99051 |
|
1,041 |
998 |
$0.00 |